composto, composição, e, métodos de inibição da atividade hdac, e de tratamento de uma doença responsiva a um inibidor de atividade hdac

This invention relates to compounds and methods for the inhibition of HDAC enzymatic activity. More particularly, the invention provides for compounds of formula (I), (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mix...

Full description

Saved in:
Bibliographic Details
Main Authors Robert Déziel, David Smil, Roger Machaalani, Sylvie Frechette, John Mancuso, Oscar Moradei, Tammy Mallais, Alain Ajamian, Silvana Leit, Patrick Beaulieu, Pierre Tessier
Format Patent
LanguagePortuguese
Published 24.09.2019
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:This invention relates to compounds and methods for the inhibition of HDAC enzymatic activity. More particularly, the invention provides for compounds of formula (I), (I) and N-oxides, hydrates, solvates, pharmaceutically acceptable salts, prodrugs and complexes thereof, and racemic and scalemic mixtures, diastereomers and enantiomers thereof, wherein L, M, n, R, W, X and Y are as defined in the specification.
Bibliography:Application Number: BR2008PI17897